{"brief_title": "Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide", "brief_summary": "This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication", "condition": ["Diabetes Mellitus, Non-Insulin-Dependent"], "intervention_type": ["Drug"], "intervention_name": ["Pramlintide acetate"], "description": ["Clear, colorless, sterile solution for SC injection."], "arm_group_label": ["Pramlintide acetate (AC137)"], "criteria": "Inclusion Criteria: - Type 2 diabetes mellitus treated with diet and/or oral agents - HbA1c 6.5-11.0", "gender": "All", "minimum_age": "18 Years", "maximum_age": "60 Years", "healthy_volunteers": "No", "keyword": "Diabetes Mellitus, Type 2", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Pramlintide", "Islet Amyloid Polypeptide"], "id": "NCT00044707"}